Business Description
Active Biotech AB
ISIN : SE0001137985
Compare
Compare
Traded in other countries / regions
ACTI.SwedenBTPC.Germany0GQU.UK IPO Date
2000-02-28Description
Active Biotech AB focuses on the research and development of pharmaceuticals products within medical areas including neurodegenerative diseases, autoimmune/inflammatory disease and various forms of cancer. Its project portfolio contains both small molecules that are orally active immunomodulatory agents and antibody based immunotherapy.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.93 | |||||
| Equity-to-Asset | 0.09 | |||||
| Debt-to-Equity | 4.65 | |||||
| Debt-to-EBITDA | -0.12 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -5.5 | |||||
| 3-Year EPS without NRI Growth Rate | -2.7 | |||||
| 3-Year FCF Growth Rate | 0.1 | |||||
| 3-Year Book Growth Rate | -24.2 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 20.38 | |||||
| 9-Day RSI | 34.92 | |||||
| 14-Day RSI | 41.37 | |||||
| 6-1 Month Momentum % | -23.19 | |||||
| 12-1 Month Momentum % | -35.05 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.91 | |||||
| Quick Ratio | 0.91 | |||||
| Cash Ratio | 0.58 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -13.7 | |||||
| Shareholder Yield % | -2.4 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -201.28 | |||||
| ROA % | -123.77 | |||||
| ROIC % | -294.45 | |||||
| ROC (Joel Greenblatt) % | -859.37 | |||||
| ROCE % | -176.15 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 110.6 | |||||
| EV-to-EBIT | -3.33 | |||||
| EV-to-EBITDA | -3.33 | |||||
| EV-to-FCF | -3.64 | |||||
| Earnings Yield (Greenblatt) % | -29.96 | |||||
| FCF Yield % | -24.02 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Active Biotech AB Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | |||
| EPS (TTM) (kr) | -0.18 | ||
| Beta | 3.16 | ||
| Volatility % | 71.44 | ||
| 14-Day RSI | 41.37 | ||
| 14-Day ATR (kr) | 0.041056 | ||
| 20-Day SMA (kr) | 0.5798 | ||
| 12-1 Month Momentum % | -35.05 | ||
| 52-Week Range (kr) | 0.4005 - 1.478 | ||
| Shares Outstanding (Mil) | 361.74 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Active Biotech AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Active Biotech AB Stock Events
| Event | Date | Price(kr) | ||
|---|---|---|---|---|
| No Event Data | ||||
Active Biotech AB Frequently Asked Questions
What is Active Biotech AB(OSTO:ACTI)'s stock price today?
The current price of OSTO:ACTI is kr0.55. The 52 week high of OSTO:ACTI is kr1.48 and 52 week low is kr0.40.
When is next earnings date of Active Biotech AB(OSTO:ACTI)?
The next earnings date of Active Biotech AB(OSTO:ACTI) is 2024-05-03 Est..
Does Active Biotech AB(OSTO:ACTI) pay dividends? If so, how much?
Active Biotech AB(OSTO:ACTI) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers